Uterine Fibroids

JAMA. 2024 May 7;331(17):1492-1493. doi: 10.1001/jama.2024.0447.

Authors

Erica E Marsh^{1

2}, Ganesa Wegienka³, David R Williams⁴

Affiliations

¹ Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor.
² Michigan Institute of Clinical and Health Research, University of Michigan, Ann Arbor.
³ Department of Obstetrics, Gynecology, and Reproductive Sciences, Michigan State University, East Lansing.
⁴ Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

PMID: 38598205
DOI: 10.1001/jama.2024.0447

No abstract available

Plain language summary

This JAMA Insights in the Women’s Health series discusses the incidence, diagnosis, and treatment of uterine fibroids.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Black or African American / statistics & numerical data
Female
Humans
Hysterectomy
Leiomyoma* / diagnosis
Leiomyoma* / epidemiology
Leiomyoma* / ethnology
Leiomyoma* / therapy
Middle Aged
United States / epidemiology
Uterine Neoplasms* / diagnosis
Uterine Neoplasms* / epidemiology
Uterine Neoplasms* / ethnology
Uterine Neoplasms* / therapy
White / statistics & numerical data